Monetary Management Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.83M | Buy |
35,105
+875
| +3% | +$188K | 1.81% | 10 |
|
|
2026
Q1 | $7.44M | Hold |
34,230
| – | – | 1.78% | 11 |
|
|
2025
Q4 | $7.82M | Sell |
34,230
-1,135
| -3% | -$259K | 1.81% | 9 |
|
|
2025
Q3 | $8.19M | Sell |
35,365
-1,000
| -3% | -$204K | 1.88% | 10 |
|
|
2025
Q2 | $6.75M | Sell |
36,365
-50
| -0.1% | -$9.29K | 1.66% | 11 |
|
|
2025
Q1 | $7.63M | Sell |
36,415
-200
| -0.5% | -$38.9K | 2.06% | 10 |
|
|
2024
Q4 | $6.51M | Buy |
36,615
+100
| +0.3% | +$18.4K | 1.69% | 10 |
|
|
2024
Q3 | $7.21M | Sell |
36,515
-1,150
| -3% | -$215K | 1.85% | 10 |
|
|
2024
Q2 | $6.46M | Buy |
37,665
+384
| +1% | +$63.6K | 1.71% | 10 |
|
|
2024
Q1 | $6.79M | Sell |
37,281
-434
| -1% | -$74.8K | 1.89% | 10 |
|
|
2023
Q4 | $5.84M | Buy |
37,715
+260
| +0.7% | +$37.9K | 1.82% | 9 |
|
|
2023
Q3 | $5.58M | Sell |
37,455
-6,850
| -15% | -$1.01M | 1.86% | 9 |
|
|
2023
Q2 | $5.97M | Sell |
44,305
-5,725
| -11% | -$840K | 1.83% | 9 |
|
|
2023
Q1 | $7.97M | Buy |
50,030
+675
| +1% | +$103K | 2.35% | 5 |
|
|
2022
Q4 | $7.98M | Sell |
49,355
-1,375
| -3% | -$211K | 2.49% | 5 |
|
|
2022
Q3 | $6.81M | Sell |
50,730
-350
| -0.7% | -$50.2K | 2.24% | 7 |
|
|
2022
Q2 | $7.82M | Sell |
51,080
-500
| -1% | -$76.4K | 2.45% | 6 |
|
|
2022
Q1 | $8.36M | Sell |
51,580
-500
| -1% | -$72.6K | 2.21% | 6 |
|
|
2021
Q4 | $7.05M | Buy |
52,080
+2,800
| +6% | +$331K | 1.74% | 9 |
|
|
2021
Q3 | $5.32M | Buy |
49,280
+5,450
| +12% | +$623K | 1.46% | 10 |
|
|
2021
Q2 | $4.94M | Sell |
43,830
-50
| -0.1% | -$5.63K | 1.49% | 10 |
|
|
2021
Q1 | $4.75M | Sell |
43,880
-1,825
| -4% | -$195K | 1.49% | 10 |
|
|
2020
Q4 | $4.9M | Sell |
45,705
-150
| -0.3% | -$14.4K | 1.61% | 11 |
|
|
2020
Q3 | $4.02M | Sell |
45,855
-1,375
| -3% | -$129K | 1.43% | 13 |
|
|
2020
Q2 | $4.64M | Sell |
47,230
-270
| -0.6% | -$23.8K | 1.75% | 9 |
|
|
2020
Q1 | $3.62M | Buy |
47,500
+4,800
| +11% | +$409K | 1.6% | 12 |
|
|
2019
Q4 | $3.78M | Sell |
42,700
-1,885
| -4% | -$156K | 1.38% | 14 |
|
|
2019
Q3 | $3.38M | Buy |
44,585
+8,170
| +22% | +$560K | 1.28% | 19 |
|
|
2019
Q2 | $2.65M | Buy |
36,415
+575
| +2% | +$45.2K | 1.02% | 26 |
|
|
2019
Q1 | $2.89M | Hold |
35,840
| – | – | 1.14% | 24 |
|
|
2018
Q4 | $3.3M | Sell |
35,840
-125
| -0.3% | -$11K | 1.49% | 14 |
|
|
2018
Q3 | $3.4M | Sell |
35,965
-5,810
| -14% | -$551K | 1.3% | 19 |
|
|
2018
Q2 | $3.87M | Sell |
41,775
-350
| -0.8% | -$34.2K | 1.58% | 18 |
|
|
2018
Q1 | $3.99M | Sell |
42,125
-375
| -0.9% | -$41.2K | 1.65% | 17 |
|
|
2017
Q4 | $4.11M | Sell |
42,500
-200
| -0.5% | -$18.8K | 1.66% | 16 |
|
|
2017
Q3 | $3.79M | Sell |
42,700
-3,200
| -7% | -$244K | 1.6% | 14 |
|
|
2017
Q2 | $3.33M | Sell |
45,900
-50
| -0.1% | -$3.36K | 1.36% | 25 |
|
|
2017
Q1 | $2.99M | Buy |
45,950
+425
| +0.9% | +$26.7K | 1.3% | 25 |
|
|
2016
Q4 | $2.85M | Buy |
45,525
+75
| +0.2% | +$4.58K | 1.32% | 24 |
|
|
2016
Q3 | $2.87M | Sell |
45,450
-575
| -1% | -$37.2K | 1.33% | 25 |
|
|
2016
Q2 | $2.85M | Buy |
46,025
+177
| +0.4% | +$10.8K | 1.33% | 22 |
|
|
2016
Q1 | $2.62M | Hold |
45,848
| – | – | 1.27% | 23 |
|
|
2015
Q4 | $2.72M | Buy |
45,848
+200
| +0.4% | +$11.5K | 1.3% | 25 |
|
|
2015
Q3 | $2.48M | Sell |
45,648
-2,000
| -4% | -$130K | 1.24% | 25 |
|
|
2015
Q2 | $3.2M | Buy |
47,648
+1,675
| +4% | +$109K | 1.44% | 16 |
|
|
2015
Q1 | $2.69M | Buy |
45,973
+9,200
| +25% | +$556K | 1.19% | 22 |
|
|
2014
Q4 | $2.41M | Buy |
36,773
+9,025
| +33% | +$569K | 1.07% | 29 |
|
|
2014
Q3 | $1.6M | Buy |
27,748
+3,600
| +15% | +$200K | 0.74% | 43 |
|
|
2014
Q2 | $1.36M | Buy |
24,148
+4,900
| +25% | +$257K | 0.64% | 54 |
|
|
2014
Q1 | $989K | Sell |
19,248
-19,875
| -51% | -$1M | 0.46% | 68 |
|
|
2013
Q4 | $2.07M | Buy |
39,123
+250
| +0.6% | +$12.3K | 0.96% | 38 |
|
|
2013
Q3 | $1.74M | Hold |
38,873
| – | – | 0.91% | 44 |
|
|
2013
Q2 | $1.61M | Buy |
+38,873
| New | +$1.7M | 0.88% | 38 |
|
Other funds holding ABBV
Monetary Management Group's ABBV Position: Q2 2026 in Review
Monetary Management Group increased its AbbVie (ABBV) stake by 2.6% in Q2 2026, buying an estimated $188K and bringing the position to 35,105 shares worth $8.83M. The position accounts for 1.81% of the portfolio, ranked #10.
Monetary Management Group first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Monetary Management Group held 35,105 shares of AbbVie worth $8.83M as of Q2 2026.
- Monetary Management Group bought 875 AbbVie shares in Q2 2026, an estimated $188K.
- AbbVie made up 1.81% of Monetary Management Group's portfolio in Q2 2026, its #10 holding.
- Monetary Management Group first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Monetary Management Group's 13F filing for Q2 2026, filed 12 Aug 2026.